Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavan Reddy

Showing results (151-160 of 228) with videos related to

Pageof 23
Sort By:
Pediatric Blood & Cancer|March 24, 2026
Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell TransplantKristen L Votruba, Michelle Rozwadowski, Thomas Braun, et al.
Bone Marrow Transplantation|February 28, 2019
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survivalGrant Chappell, Marcus Geer, Erin Gatza, et al.
Research Square|March 22, 2023
Inflammatory memory restrains intestinal stem cell regenerationPavan Reddy, Dongchang Zhao, Visweswaran Ravikumar, et al.
Scientific Reports|August 22, 2018
Murine Models of Steroid Refractory Graft-versus-Host DiseaseTomomi Toubai, Corinne Rossi, Isao Tawara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantationIsao Tawara, Motoko Koyama, Chen Liu, et al.
Blood|October 22, 2013
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host diseaseShan He, Fang Xie, Yongnian Liu, et al.
Blood|March 23, 2013
Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantationTomomi Toubai, Yaping Sun, Gary Luker, et al.
JCI Insight|July 21, 2017
Siglec-G represses DAMP-mediated effects on T cellsTomomi Toubai, Corinne Rossi, Katherine Oravecz-Wilson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2019
Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic TransplantationJohn Magenau, Thomas Braun, Erin Gatza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2018
Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic TransplantationTomomi Toubai, Hiroya Tamaki, Daniel C Peltier, et al.
Pageof 23

Showing results (151-160 of 228) with videos related to

Sort By:
Pageof 23
Pediatric Blood & Cancer|March 24, 2026
Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell TransplantKristen L Votruba, Michelle Rozwadowski, Thomas Braun, et al.
Bone Marrow Transplantation|February 28, 2019
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survivalGrant Chappell, Marcus Geer, Erin Gatza, et al.
Research Square|March 22, 2023
Inflammatory memory restrains intestinal stem cell regenerationPavan Reddy, Dongchang Zhao, Visweswaran Ravikumar, et al.
Scientific Reports|August 22, 2018
Murine Models of Steroid Refractory Graft-versus-Host DiseaseTomomi Toubai, Corinne Rossi, Isao Tawara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantationIsao Tawara, Motoko Koyama, Chen Liu, et al.
Blood|October 22, 2013
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host diseaseShan He, Fang Xie, Yongnian Liu, et al.
Blood|March 23, 2013
Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantationTomomi Toubai, Yaping Sun, Gary Luker, et al.
JCI Insight|July 21, 2017
Siglec-G represses DAMP-mediated effects on T cellsTomomi Toubai, Corinne Rossi, Katherine Oravecz-Wilson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2019
Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic TransplantationJohn Magenau, Thomas Braun, Erin Gatza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2018
Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic TransplantationTomomi Toubai, Hiroya Tamaki, Daniel C Peltier, et al.
Pageof 23